New anti-cemiplimab (Libtayo) antibodies that inhibit PD-1 binding. Select conjugated anti-drug antibodies ready for bioanalysis and drug-monitoring assays.
Bio-Rad launched Bio-Plex SARS-CoV-2 Variant Neutralization Antibody Assays for RUO that help to efficiently measure neutralizing antibodies against wild-type & SARS-CoV-2 variants.
StarBright UltraViolet 400 Dye Offers Maximal Brightness and Narrow Excitation and Emission Profiles for Precise Resolution
The CFX Opus 96 Dx System and the CFX Opus 384 Dx Real-Time PCR Systems Offer Accurate and Precise Quantification to Improve IVD Assay Development and Diagnostic Testing
The Panels Complete Bio-Rad’s Set of Bio-Plex Multiplex SARS-CoV-2 Human Serology Panels for Detection of Antibodies Against Four SARS-CoV-2 Antigens
Labs in Europe that perform standard COVID-19 testing can now test for SARS-CoV-2, influenza A, and influenza B simultaneously during the flu season, using the Reliance SARS-CoV-2/FluA/FluB™ RT-PCR Kit (IVD).
The solution includes chromogenic medium and a selective supplement that can detect these bacteria without the need for a confirmation step, delivering results in less than 24 hours.
